Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Low-level miR-646 in colorectal cancer inhibits cell proliferation and migration by targeting NOB1 expression
Huajia Dai1, Kezhu Hou1, Zujin Cai1
1The First Department of General Surgery, Shidong Hospital, Shanghai 200438, P.R. China.
Abstract:
Aberrant expression of microRNA (miRNA) is important in the progression of various human cancers, however further investigation is required in order to fully elucidate mechanisms of and validate actions of endogenous non-coding RNAs. The present study demonstrated that the expression of miR-646 was downregulated in colorectal cancer tissues and cell lines. Notably, it was observed that miR-646, a tumor suppressor, inhibited colorectal cancer cell progression through directly targeting Nin one binding protein (NOB1) expression, which possesses anti-tumor properties in colorectal cancer. Furthermore, knockdown of NOB1 expression was responsible for the tumor-suppressive effect of miR-646. The findings suggest that miR-646 may act as a therapeutic target for the treatment of colorectal cancer.
Insights
MicroRNA-646 (miR-646) is downregulated in colorectal cancer, acting as a tumor suppressor. It inhibits cancer progression by targeting Nin one binding protein (NOB1), suggesting miR-646 as a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant microRNA (miRNA) expression is implicated in human cancer progression.
- Further research is needed to understand the roles of non-coding RNAs in cancer.
- Colorectal cancer (CRC) pathogenesis involves complex molecular alterations.
Purpose of the Study:
- To investigate the role of miR-646 in colorectal cancer.
- To identify the molecular targets of miR-646 in CRC.
- To evaluate the therapeutic potential of miR-646 in CRC.
Main Methods:
- Quantitative real-time PCR to assess miR-646 expression in CRC tissues and cell lines.
- Bioinformatic analysis to predict targets of miR-646.
- Luciferase reporter assays and Western blotting to validate NOB1 as a direct target.
- Cell proliferation and migration assays to assess the functional role of miR-646 and NOB1.
Main Results:
- miR-646 expression was significantly downregulated in colorectal cancer tissues and cell lines compared to normal controls.
- miR-646 directly targeted and suppressed the expression of Nin one binding protein (NOB1).
- NOB1 possesses anti-tumor properties in colorectal cancer.
- Knockdown of NOB1 mimicked the tumor-suppressive effects of miR-646, confirming its role in mediating miR-646's action.
Conclusions:
- miR-646 functions as a tumor suppressor in colorectal cancer.
- The miR-646/NOB1 axis plays a critical role in regulating CRC cell progression.
- miR-646 represents a promising therapeutic target for colorectal cancer treatment.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Targeted Cancer Therapies
There are several types of targeted therapies against...
Feedback Inhibition
Cell Migration
Cell Migration
Cells Coordinate Growth and Proliferation

